Aziz Mallik’s Post

The IQVIA Digital Health Trends 2024 report highlights the shift from standalone tools to integrated digital care platforms. Despite funding challenges, the sector is maturing with new reimbursement pathways, regulatory support, and sustainable business models. 🔴 Key Segments 1️⃣ Consumer Apps: Out of 1M health apps, only 337K remain active, with a shift toward gated access models requiring prescriptions or payer approval for high-quality apps. 2️⃣ Digital Therapeutics (#DTx): Over 360 DTx are available globally, led by Germany (56 reimbursed DTx) and the U.S. (46 DTx). Expansion includes biofeedback, VR, and pain management. 3️⃣ #Wearables & Sensors: Remote patient monitoring (RPM) has grown fivefold in the U.S., with wearables and digital #biomarkers supporting chronic disease management and drug trials. 4️⃣ Digital Diagnostics: Over 800 FDA-approved AI/ML diagnostic tools detect conditions like autism, epilepsy, and sepsis, shifting diagnostics from specialists to general practitioners. 🔴 Investment & Adoption 1️⃣ Funding Decline: Investment fell from $59.3B (2021) to $22.8B (2023) but began recovering in Q2 2024. 2️⃣ Adoption Shift: Blended care models (telehealth + DTx) are reshaping chronic disease care. Companies are shifting from standalone tools to all-in-one care platforms. 🔴 Outlook for 2025 1️⃣Blended Care Models: Telehealth, RPM, and DTx will converge into integrated platforms. 2️⃣OTC DTx: Some prescription DTx may shift to over-the-counter (OTC) models, improving access. 3️⃣Platform Economy: Companies will consolidate products into holistic care platforms that support providers, payers, and patients. Link: https://lnkd.in/eDffPsZw

 What are the most coveted health data types in the Industry? 📊 Patient health data Electronic Health Records (EHRs) and patient data are among the most valuable assets. They include diagnoses, treatments, outcomes, and medical histories used for patient monitoring, clinical research, and therapy improvement. 📊 Genomic data Genomic data provides a deep understanding of diseases at the molecular level, paving the way for personalized medicine and targeted therapies. 📊 Clinical trial data Clinical trial data is critical for gaining regulatory approvals and understanding treatment efficacy. It includes adverse effects, effectiveness metrics, and comparative analyses, making it a costly but invaluable resource. 📊 Connected medical device data Health data from wearables and connected devices (e.g., fitness trackers, remote sensors) offers real-time insights into patient health. 📊 Healthcare cost and reimbursement data Data on healthcare costs, reimbursement models (insurance, mutual funds), and patient expenditures provides a critical view of the economic landscape. Hospitals, insurers, and policymakers rely on these insights to optimize healthcare systems. 📊 Pharmaceutical prescription data Prescription data is key for pharma companies, revealing doctors' prescribing behaviors and medication consumption trends. This insight enables more targeted marketing campaigns and guides R&D towards unmet market needs. 📊 Public health data Epidemiological and public health data provide population-level insights into disease prevalence, mortality rates, and risk factors. This data supports health planning, crisis management (like COVID-19), and public health policies. 📊 Patient behavioral data Behavioral data includes treatment adherence, lifestyle choices (diet, exercise), and care preferences. It offers valuable insights into the factors affecting health, enabling personalized interventions. 📊 AI and machine learning data AI companies collect vast amounts of health data to train their models. These algorithms can then predict clinical outcomes, diagnose diseases early, and optimize treatments. 

A must read to stay ahead of the latest trends in #DigitalHealth #MedTech #Digital #Healthcare IQVIA MedTech

🚀 Exciting News! 🚀 I'm thrilled to announce that the "Digital Health Trends 2024: Implications for Research and Patient Care - Volume 1" report is now published! 🎉 It has been an incredible journey collaborating with the IQVIA Institute to bring this insightful analysis to life. 📘 Why Read It? This report delves into the ever-evolving landscape of digital health over the past two years, highlighting the emergence of commercially viable products that meet the needs of stakeholders across a broadening set of uses. These innovations span the full patient journey, from digital diagnostics to mature digital therapies, aiming to speed care and close gaps to improve health outcomes. If you are part of the healthcare ecosystem or interested in digital health solutions and trends, click on the link below for this must-read report! 🔍 Key Findings: - Digital Health Apps: With ~337,000 apps available, you'll find learnings across therapeutic areas, including the evolution of disease-specific apps beyond mental health and chronic diseases to other conditions. - Approval and Reimbursement: Accelerating as payers recognize clinical utility and cost savings, with over 360 software-based digital therapies available, including 140 prescription digital therapeutics for home use. - Sensor-Based Digital Biomarkers: Wearables now monitor patients in care and research, with the first digital endpoints approved by regulators in the U.S. and Europe. - Digital Diagnostics: Over 103 digital diagnostics are commercially available, using AI/ML to evaluate disease risk, accelerate diagnosis, and monitor patient health. Stay tuned for Volume 2, coming early 2025, where we'll explore how business strategies are shifting, the pathways digital products take to reach the market, and the evolving payer evidence requirements and government policies globally. Keep an eye out for more updates! If you are interested in learning more, or exploring specific sections of the report with us, please reach out to me or our team Deanna Nass Robert B. Kate Bennet Oliver Bailey Erika Szewkies Anna Exenberger, PhD Michael Krupnick https://lnkd.in/e8tTNzDs #DigitalHealth #HealthcareInnovation #IQVIA #Research #PatientCare #HealthTech

𝐓𝐡𝐞 𝐒𝐭𝐚𝐭𝐞 𝐨𝐟 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐠𝐥𝐨𝐛𝐚𝐥 𝐫𝐞𝐜𝐚𝐩 𝐫𝐞𝐩𝐨𝐫𝐭 2024 🚀 by CB Insights 🌐 Exciting insights ahead! Dive into the "State of Digital Health Global Recap Report 2024" by CB Insights. This comprehensive report sheds light on the latest trends, innovations, and challenges shaping the digital health landscape worldwide. From AI advancements to the integration of smart devices and wearables, discover how these technologies are transforming patient care and healthcare operations. Whether you're a healthcare professional, tech enthusiast, or industry leader, this report is a must-read to stay ahead in the ever-evolving world of digital health. 𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 𝐬𝐨𝐦𝐞 𝐤𝐞𝐲 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: 1️⃣ 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐞𝐚𝐥 𝐒𝐢𝐳𝐞: The median digital health deal size reached a record high of $5.3 million in 2024, investors are focusing their resources on companies with strong clinical validation, commercial traction & regulatory readiness. 2️⃣ 𝐀𝐈 𝐢𝐧 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡: AI-focused companies captured 42% of digital health funding and 31% of deals in 2024, both record highs. The largest AI-focused deals were in diagnostics, drug development & women's health. 3️⃣ 𝐌𝐞𝐠𝐚-𝐑𝐨𝐮𝐧𝐝𝐬 𝐒𝐮𝐫𝐠𝐞: Mega-rounds ($100 million+ deals) saw a 50% year-over-year increase in 2024, with the top deals centered on drug discovery and development. The majority of these high-value deals were in the U.S. 4️⃣ 𝐃𝐞𝐜𝐥𝐢𝐧𝐞 𝐢𝐧 𝐃𝐞𝐚𝐥 𝐂𝐨𝐮𝐧𝐭: Despite a slight 3% increase in digital health funding, the overall deal count dropped by 23% year-over-year, marking the lowest annual total since 2014. Europe experienced the sharpest decline in deal activity. 5️⃣ 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐓𝐫𝐞𝐧𝐝𝐬: In Q4 2024, the U.S. led with $2.3 billion across 170 deals, while Asia and Europe followed with $0.1 billion and $0.7 billion, respectively. This highlights the U.S.'s continued dominance in digital health investments. 6️⃣ 𝐓𝐨𝐩 𝐄𝐪𝐮𝐢𝐭𝐲 𝐃𝐞𝐚𝐥𝐬: Significant deals in Q4 2024 included Enveda's $130 million Series C, Maven's $125 million Series F, and Cleerly's $106 million Series C, all based in the U.S. 7️⃣ 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐓𝐫𝐞𝐧𝐝𝐬: The report notes a shift towards larger, more selective investments, with a focus on early-stage companies in the U.S. and Europe. 8️⃣ 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐒𝐭𝐚𝐫𝐭𝐮𝐩𝐬: The report features over 180 high-potential startups, emphasizing the dynamic nature of the digital health landscape. Featuring : ŌURA | Enveda | Maven Clinic | Cleerly | Precision Neuroscience | Glooko | Remodel Health | Cortica | Vesalius Therapeutics | Cradle These highlights provide a snapshot of the evolving digital health industry, showcasing the growing role of AI, the concentration of investments in high-potential companies & regional investment dynamics. Let's embrace the future of healthcare together! 🚀 #DigitalHealth #AIinHealthcare #HealthcareTransformation

Key findings from IQVIA’s Digital Health Trends 2024 The landscape of digital health is evolving rapidly, with notable challenges and opportunities shaping the field. Below the key findings: 1️⃣ Innovation Amid Challenges: Despite funding declines and market pressures, new digital health products are gaining traction by integrating seamlessly into care pathways and combining patient- and provider-facing solutions. 2️⃣ Consumer Apps Shift: Over 1 million health apps have been launched since 2008, yet only 337,000 remain active. Apps with stronger clinical evidence are gaining traction, underlining the growing importance of evidence-based solutions. 3️⃣ Digital Therapeutics Growth: Over 360 software-based therapies are commercially available, with Germany and the U.S. leading in reimbursement pathways. Applications range from mental health to diabetes, hypertension, and beyond. 4️⃣ Sensor-Based Monitoring: Wearables and digital biomarkers are transforming remote monitoring and clinical trials, offering nuanced health insights while reducing patient burdens. 5️⃣ Emerging Care Models: Blended care programs that combine telemedicine with digital tools are gaining momentum for chronic conditions like obesity and mental health, addressing gaps in continuous care. 6️⃣ Global Adoption Trends: Reimbursement pathways are critical. Countries like Germany have embraced digital health, while the U.S. faces commercialization challenges due to reimbursement gaps. 7️⃣ Integration Over Isolation: Developers are shifting from standalone products to platform solutions that address broader healthcare needs, making adoption easier for providers and patients. The future of digital health lies in creating clinically validated, user-centered solutions that integrate into existing systems and deliver measurable outcomes. #DigitalHealth #HealthTech 

𝐓𝐡𝐞 𝐒𝐭𝐚𝐭𝐞 𝐨𝐟 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐠𝐥𝐨𝐛𝐚𝐥 𝐫𝐞𝐜𝐚𝐩 𝐫𝐞𝐩𝐨𝐫𝐭 2024 🌐 Exciting insights ahead! Dive into the "State of Digital Health Global Recap Report 2024" by CB Insights. This comprehensive report sheds light on the latest trends, innovations, and challenges shaping the digital health landscape worldwide. From AI advancements to the integration of smart devices and wearables, discover how these technologies are transforming patient care and healthcare operations. Whether you're a healthcare professional, tech enthusiast, or industry leader, this report is a must-read to stay ahead in the ever-evolving world of digital health. 𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 𝐬𝐨𝐦𝐞 𝐤𝐞𝐲 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬: 1️⃣ 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐞𝐚𝐥 𝐒𝐢𝐳𝐞: The median digital health deal size reached a record high of $5.3 million in 2024, investors are focusing their resources on companies with strong clinical validation, commercial traction & regulatory readiness. 2️⃣ 𝐀𝐈 𝐢𝐧 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡: AI-focused companies captured 42% of digital health funding and 31% of deals in 2024, both record highs. The largest AI-focused deals were in diagnostics, drug development & women's health. 3️⃣ 𝐌𝐞𝐠𝐚-𝐑𝐨𝐮𝐧𝐝𝐬 𝐒𝐮𝐫𝐠𝐞: Mega-rounds ($100 million+ deals) saw a 50% year-over-year increase in 2024, with the top deals centered on drug discovery and development. The majority of these high-value deals were in the U.S. 4️⃣ 𝐃𝐞𝐜𝐥𝐢𝐧𝐞 𝐢𝐧 𝐃𝐞𝐚𝐥 𝐂𝐨𝐮𝐧𝐭: Despite a slight 3% increase in digital health funding, the overall deal count dropped by 23% year-over-year, marking the lowest annual total since 2014. Europe experienced the sharpest decline in deal activity. 5️⃣ 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 𝐓𝐫𝐞𝐧𝐝𝐬: In Q4 2024, the U.S. led with $2.3 billion across 170 deals, while Asia and Europe followed with $0.1 billion and $0.7 billion, respectively. This highlights the U.S.'s continued dominance in digital health investments. 6️⃣ 𝐓𝐨𝐩 𝐄𝐪𝐮𝐢𝐭𝐲 𝐃𝐞𝐚𝐥𝐬: Significant deals in Q4 2024 included Enveda's $130 million Series C, Maven's $125 million Series F, and Cleerly's $106 million Series C, all based in the U.S. 7️⃣ 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐓𝐫𝐞𝐧𝐝𝐬: The report notes a shift towards larger, more selective investments, with a focus on early-stage companies in the U.S. and Europe. 8️⃣ 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐒𝐭𝐚𝐫𝐭𝐮𝐩𝐬: The report features over 180 high-potential startups, emphasizing the dynamic nature of the digital health landscape. 💟 To gain monthly insights on #technology & #innovations, subscribe to #global5gevolution newsletter (https://lnkd.in/ge9gsyjE) & tune in for latest edition on “5G-Advanced” 💟 Or subscribe to #global5gevolution YouTube channel (https://lnkd.in/g8M7YvKq) & tune in for latest episode “Industry5.0 ORAN Rel19 IoT”; click comment box 💟 Follow us on Kaneshwaran Govindasamy & Global 5G Evolution #DigitalHealth #AIinHealthcare #HealthcareTransformation

Enhancing the competitiveness of the #healthsector through #ai. The potential applications of harnessing #patientcentred data are far-reaching: Preventing #chronic #diseases: Utilizing patient-level data and analytics to proactively address chronic diseases such as diabetes and metabolic disorders. #Early #diagnosis: Employing data modelling and artificial intelligence (AI) in diagnostics, genetics and image recognition to identify life-threatening diseases in their nascent stages. #Remote #chronic condition management: Leveraging connected devices and real-time interventions to manage chronic conditions beyond traditional healthcare settings. Promoting #health #equity: Facilitating global access to healthcare, thereby accelerating the journey towards health equity on a global scale. https://lnkd.in/dX9eQ6c7 MedTech Europe COCIR Fenin, Federación Española de Empresas de Tecnología Sanitaria World Economic Forum #thehumansideoftechmed

🚀 The Global Digi-Health Monitor: Stay tuned and stay informed! https://lnkd.in/emKW_zCn 𝗧𝗵𝗶𝘀 𝘄𝗲𝗲𝗸 𝗮𝘁 𝗮 𝗴𝗹𝗮𝗻𝗰𝗲: • 𝗧𝗵𝗲 𝗔𝗜 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻: Unveiling the Global Players and Market Dynamics • 𝗧𝗵𝗲 𝗗𝗮𝗿𝗸 𝗦𝗶𝗱𝗲 𝗼𝗳 𝗢𝗻𝗹𝗶𝗻𝗲 𝗪𝗲𝗶𝗴𝗵𝘁-𝗟𝗼𝘀𝘀 𝗗𝗿𝘂𝗴𝘀: Risks, Knock-Offs, and Dangerous Bargains • 𝗗𝗶𝘀𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱: The Impact of the Affordable Connectivity Program’s End on Veterans and Service Members • 𝗧𝗵𝗲 𝗥𝗶𝘀𝗲 𝗼𝗳 𝗛𝗼𝗺𝗲 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲:  Innovations, Aging Populations, and Pandemic Pressures • 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗲𝗿𝗶𝗺𝗲𝗻𝗼𝗽𝗮𝘂𝘀𝗮𝗹 𝗧𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻: Nutrition, Exercise, and Sleep Strategies for Women’s Health ✨ Combining state-of-the-art AI with human oversight, we cut through the noise of information, delivering tailored, engaging, and relevant news from across the globe.  🔍 Expect highly curated news on everything digital in the global healthcare economy, sourced from over 1,000 articles each week. The AI-driven personalized content engine from NewsButler gathers, prioritizes, and synthesizes the most important news based on our keyword parameters. Our team then reviews and further curates these results to bring you the most relevant and exciting updates each week. Follow us for the latest updates and breakthroughs in the digital healthcare economy! 🌟 #DigitalHealth #AI #HealthcareInnovation #GlobalHealth #HealthTech #AIInHealthcare #Telehealth #MedicalTech #HealthNews

Even the most conservative projections estimate that the US Digital Biomarker market will grow at a CAGR of 22.86% to $8.59 billion by 2029. It stood at $2.49 billion at the end of 2023! What does it mean for you? As a Healthcare Provider, how can you best ride this trend? And what are the implementation challenges that you should know about? Here's a quick read answering all your questions - https://lnkd.in/dzwbsmpz #digitalhealth #healthtech #continuouscare